B G M Durie

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

William S. Dalton, Thomas M. Grogan, Paul S. Meltzer et al. · Journal of Clinical Oncology · 1989 · 560 citations

Immunology, Continuous Infusion Verapamil, Pathology +17

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 348 citations · Full text

Hematological Malignancy, Proteasome Inhibitors, Relapsed Myeloma +10

Modulation of multidrug-resistant multiple myeloma by cyclosporin

Pieter Sonneveld, Bob Löwenberg, B G M Durie et al. · The Lancet · 1992 · 315 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +5

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

Sergio Giralt, Edward A. Stadtmauer, Jean‐Luc Harousseau et al. · Leukemia · 2009 · 228 citations

Hematological Malignancy, Stem Cell Collection, Oncology +10

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.

B G M Durie, Dennis O. Dixon, S Carter et al. · Journal of Clinical Oncology · 1986 · 89 citations